Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives.

about

Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives.

Item

http://www.wikidata.org/entity/Q47129584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of metabolic disorders ...... sulin resistance perspectives.

@en

Impact of metabolic disorders ...... sulin resistance perspectives.

@nl

type

Item

label

Impact of metabolic disorders ...... sulin resistance perspectives.

@en

Impact of metabolic disorders ...... sulin resistance perspectives.

@nl

prefLabel

Impact of metabolic disorders ...... sulin resistance perspectives.

@en

Impact of metabolic disorders ...... sulin resistance perspectives.

@nl

P1476

Impact of metabolic disorders ...... nsulin resistance perspectives

@en

P2093

Makito Tanabe

http://www.w3.org/2001/XMLSchema#string

Takako Kawanami

http://www.w3.org/2001/XMLSchema#string

Takashi Nomiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor

Obesity and cancer, a case for insulin signaling

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.

A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival

The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

P304

252-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1002/RMB2.12039

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomoko Tanaka

Tashihiko Yanase

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29259475

http://www.w3.org/2001/XMLSchema#string

P932

5715889

http://www.w3.org/2001/XMLSchema#string